Juergen B Bulitta (Jürgen B Bulitta, Jürgen Bulitta)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 56

Top Venues

Antimicrobial agents and chemotherapy

Pharmaceutics

mBio

Antibiotics (Basel, Switzerland)

University of Florida

Julius-Maximilians-Universität Würzburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Florida Jul 17 2015

United States

Associate Professor, Pre-eminence Position in Drug Discovery & Development :: Department of Pharmaceutics

Monash Institute of Pharmaceutical Sciences Aug 01 2011 - Apr 15 2015

Australia

Senior Research Fellow, ARC DECRA Fellow (2012-14), NHMRC Career Development Fellow (CDF level 2, 2015)

Ordway Research Institute Mar 22 2009 - Jul 15 2011

United States

Senior Scientist

University at Buffalo - The State University of New York Aug 15 2006 - Mar 21 2009

United States

Postdoctoral fellow :: Pharmaceutical Sciences

Institute for Biomedical and Pharmaceutical Research Jul 27 1998 - Aug 09 2007

Germany

Scientific co-worker

Education History

Julius-Maximilians-Universität Würzburg Nov 01 2003 - Sep 25 2006

Germany

PHD :: Institute of Pharmacy & Food Chemistry

Friedrich-Alexander-University Sep 15 1999 - Oct 03 2003

Germany

MSC

Publications

Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy 68 (4) (2024)
Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy 68 (4) (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy 68 (4) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Yuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, Peggy Lu, Michael Vicchiarelli, Zeferino Reyna, Juan Ruiz-Delgado, Elizabeth Burk, Eugene Moon, Nirav R Shah, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial agents and chemotherapy 68 (3) (2024)
Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed, Carolin Werkman, Yuanyuan Jiao, Monika Kumaraswamy, Zackery P Bulman, Brian M Luna, Juergen B Bulitta
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrobial agents and chemotherapy 68 (2) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy (2024)
Juergen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee, Jeffrey G Stark, Barry Hafkin
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Silvia López-Argüello, Maria Montaner, Alaa Rm Sayed, Antonio Oliver, Juergen B Bulitta, Bartolome Moya
Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology. Antimicrobial agents and chemotherapy (2023)
Jessica R Tait, Marina Harper, Sara Cortés-Lara, Kate E Rogers, Carla López-Causapé, Thomas R Smallman, Yinzhi Lang, Wee Leng Lee, Jieqiang Zhou, Juergen B Bulitta, Roger L Nation, John D Boyce, Antonio Oliver, Cornelia B Landersdorfer
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance. Antimicrobial agents and chemotherapy (2023)
Yuanyuan Jiao, Jun Yan, Michael Vicchiarelli, Dhruvitkumar S Sutaria, Peggy Lu, Zeferino Reyna, Brad Spellberg, Robert A Bonomo, George L Drusano, Arnold Louie, Brian M Luna, Juergen B Bulitta
Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice. Antimicrobial agents and chemotherapy (2023)
Hajira Bilal, Jessica R Tait, Yinzhi Lang, Jieqiang Zhou, Phillip J Bergen, Anton Y Peleg, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling. Antimicrobial agents and chemotherapy 66 (3) (2022)
Suresh Dharuman, Miranda J Wallace, Stephanie M Reeve, Juergen B Bulitta, Richard E Lee
Synthesis and Structure-Activity Relationship of Thioacetamide-Triazoles against Escherichia coli . Molecules (Basel, Switzerland) 27 (5) (2022)
Nicholas M Smith, Katie Rose Boissonneault, Liang Chen, Vidmantas Petraitis, Povilas Kavaliauskas, Xun Tao, Jieqiang Zhou, Yinzhi Lang, Povilas Kavaliauskas, Zackery P Bulman, Patricia N Holden, Raymond Cha, Juergen B Bulitta, Barry N Kreiswirth, Thomas J Walsh, Brian T Tsuji
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity. Antimicrobial agents and chemotherapy 66 (9) (2022)
Jessica R Tait, Hajira Bilal, Kate E Rogers, Yinzhi Lang, Tae-Hwan Kim, Jieqiang Zhou, Steven C Wallis, Juergen B Bulitta, Carl M J Kirkpatrick, David L Paterson, Jeffrey Lipman, Phillip J Bergen, Jason Alexander Roberts, Roger L Nation, Cornelia B Landersdorfer
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics (Basel, Switzerland) 11 (1) (2022)
Ashley N Brown, Yinzhi Lang, Jieqiang Zhou, Evelyn J Franco, Kaley C Hanrahan, Juergen B Bulitta, George L Drusano
Why Molnupiravir Fails in Hospitalized Patients. mBio (2022)
Evelyn J Franco, Xun Tao, Kaley C Hanrahan, Jieqiang Zhou, Juergen B Bulitta, Ashley N Brown
Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines. Microorganisms 9 (2) (2021)
George L Drusano, Robert A Bonomo, Steven M Marshall, Laura J Rojas, Mark D Adams, Maria F Mojica, Barry N Kreiswirth, Liang Chen, Nino Mtchedlidze, Meredith Bacci, Michael Vicchiarelli, Juergen B Bulitta, Arnold Louie
Emergence of Resistance to Ceftazidime-Avibactam in a Pseudomonas aeruginosa Isolate Producing Derepressed bla PDC in a Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 65 (6) (2021)
Juergen B Bulitta, Yuanyuan Jiao, Stefanie K Drescher, Antonio Oliver, Arnold Louie, Bartolome Moya, Xun Tao, Mathias Wittau, Brian T Tsuji, Alexandre P Zavascki, Beom Soo Shin, George L Drusano, Fritz Sörgel, Cornelia B Landersdorfer
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis. Clinical pharmacokinetics 58 (2) (2020)
Alaa R M Sayed, Nirav R Shah, Kari B Basso, Manasi Kamat, Yuanyuan Jiao, Bartolome Moya, Dhruvitkumar S Sutaria, Yinzhi Lang, Xun Tao, Weiguo Liu, Eunjeong Shin, Jieqiang Zhou, Carolin Werkman, Arnold Louie, George L Drusano, Juergen B Bulitta
First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus. Antimicrobial agents and chemotherapy 65 (1) (2020)
Tae Hwan Kim, Xun Tao, Bartolome Moya, Yuanyuan Jiao, Kari B Basso, Jieqiang Zhou, Yinzhi Lang, Dhruvitkumar S Sutaria, Alexandre P Zavascki, Afonso L Barth, Stephanie M Reeve, Herbert P Schweizer, Deanna Deveson Lucas, John D Boyce, Robert A Bonomo, Richard E Lee, Beom Soo Shin, Arnold Louie, George L Drusano, Juergen B Bulitta
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter cloacae. mBio 11 (1) (2020)
James M Byrne, Ursula Waack, Edward A Weinstein, Abhay Joshi, Simone M Shurland, Dmitri Iarikov, Juergen B Bulitta, Binh An Diep, Tina Guina, William W Hope, Matthew B Lawrenz, Alexander J Lepak, Brian M Luna, Lynn Miesel, Andrew J Phipps, Thomas J Walsh, William Weiss, Thushi Amini, John J Farley
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development. Antimicrobial agents and chemotherapy 65 (1) (2020)
Juergen B Bulitta, William W Hope, Ann E Eakin, Tina Guina, Vincent H Tam, Arnold Louie, George L Drusano, Jennifer L Hoover
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans. Antimicrobial agents and chemotherapy 63 (5) (2019)
Rajbharan Yadav, Phillip J Bergen, Kate E Rogers, Carl M J Kirkpatrick, Steven C Wallis, Yuling Huang, Juergen B Bulitta, David L Paterson, Jeffrey Lipman, Roger L Nation, Jason Alexander Roberts, Cornelia B Landersdorfer
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients. Antimicrobial agents and chemotherapy 64 (1) (2019)
Nirav R Shah, Juergen B Bulitta, Martina Kinzig, Cornelia B Landersdorfer, Yuanyuan Jiao, Dhruvitkumar S Sutaria, Xun Tao, Rainer Höhl, Gerhard Bringmann, Frieder Kees, Ulrich Stephan, Fritz Sörgel
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding. Pharmaceutics 11 (6) (2019)
Vanessa E Rees, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling. Pharmaceutics 11 (9) (2019)
Yuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, Alexandre P Zavascki, Hsinyin Tsai, Xun Tao, Dhruvitkumar S Sutaria, Arnold Louie, John D Boyce, Deanna Deveson Lucas, Tae Hwan Kim, Brian T Tsuji, Robert A Bonomo, George L Drusano, Juergen B Bulitta
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial agents and chemotherapy 63 (7) (2019)
Juergen B Bulitta, Yuanyuan Jiao, Cornelia B Landersdorfer, Dhruvitkumar S Sutaria, Xun Tao, Eunjeong Shin, Rainer Höhl, Gerhard Bringmann, Ulrich Stephan, Fritz Sörgel
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics 11 (7) (2019)
Brian M Luna, Jun Yan, Zeferino Reyna, Eugene Moon, Travis B Nielsen, Hernan Reza, Peggy Lu, Robert Bonomo, Arnold Louie, George L Drusano, Juergen B Bulitta, Rosemary C She, Brad Spellberg
Natural history of Acinetobacter baumannii infection in mice. PloS one 14 (7) (2019)
Vanessa E Rees, Deanna S Deveson Lucas, Carla López-Causapé, Yuling Huang, Tom Kotsimbos, Juergen B Bulitta, Murray C Rees, Adele Barugahare, Anton Y Peleg, Roger L Nation, Antonio Oliver, John D Boyce, Cornelia B Landersdorfer
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. Antimicrobial agents and chemotherapy 63 (4) (2019)
Dhruvitkumar S Sutaria, Bartolome Moya, Kari B Green, Tae Hwan Kim, Xun Tao, Yuanyuan Jiao, Arnold Louie, George L Drusano, Juergen B Bulitta
First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 62 (6) (2018)
Vanessa E Rees, Rajbharan Yadav, Kate E Rogers, Juergen B Bulitta, Veronika Wirth, Antonio Oliver, John D Boyce, Anton Y Peleg, Roger L Nation, Cornelia B Landersdorfer
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients. Antimicrobial agents and chemotherapy 62 (11) (2018)
Cornelia B Landersdorfer, Rajbharan Yadav, Kate E Rogers, Tae Hwan Kim, Beom Soo Shin, John D Boyce, Roger L Nation, Juergen B Bulitta
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling. Antimicrobial agents and chemotherapy 62 (4) (2018)
Rajbharan Yadav, Kate E Rogers, Phillip J Bergen, Juergen B Bulitta, Carl M J Kirkpatrick, Steven C Wallis, David L Paterson, Roger L Nation, Jeffrey Lipman, Jason A Roberts, Cornelia B Landersdorfer
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling. Antimicrobial agents and chemotherapy 62 (5) (2018)
Camilly P Pires de Mello, Xun Tao, Tae Hwan Kim, Michael Vicchiarelli, Juergen B Bulitta, Ajeet Kaushik, Ashley N Brown
Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 62 (9) (2018)

Juergen B Bulitta.css-eqlu8i{font-size:small;padding-left:4px;} (Jürgen B Bulitta, Jürgen Bulitta)

Publication Activity (10 Years)

Top Topics

Top Venues

Juergen B Bulitta (Jürgen B Bulitta, Jürgen Bulitta)